Yonhap Infomax NewsMar 18, 2025
GC Pharma's US affiliate Curevo Vaccine secures $110 million in Series B funding for shingles vaccine development, led by European VC Medicxi with participation from major healthcare investors.
#YonhapInfomax #CurevoVaccine #SeriesBFunding #ShinglesVaccine #GCPharma #ClinicalTrials #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=54474
GC Pharma's US Affiliate Curevo Secures $110 Million Series B Investment

GC Pharma's US affiliate Curevo Vaccine secures $110 million in Series B funding for shingles vaccine development, led by European VC Medicxi with participation from major healthcare investors.

Yonhap Infomax